Aortic arch calcification predicts the extent of coronary atherosclerosis in patients with or without type 2 diabetes: Short communication

Acta Clinica Belgica

Volumn 62, Issue 1, 2007, Pages 52-55

  Papanas, Nikolaos ^a,d   Tziakas, D ^a   Mavridis, G ^b   Giannakis, I ^b   Symeonidis, G ^b   Stakos, D ^a   Milousis, A ^a   Maltezos, E ^a   Louridas, G ^c   Hatseras, D ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Aristotle University and Hippokration General Hospital   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d Ethnikis Antistasis 44 ^*  (Greece)

Author keywords

Aortic calcification; Atherosclerosis; Coronary arteriography; Coronary artery disease; Diabetes mellitus; X rays

Indexed keywords

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SENSITIVITY AND SPECIFICITY;

EID: 34047111786     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2007.008     Document Type: Article

References (20)

1. Haberl RL, Dembowski K. Atherosclerosis: common factor in stroke, myocardial infarction and peripheral vascular disease. Eur Heart J Suppl 1999; 1: A41-A4.
2. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Peth S, Kopp H et al. Manifestationen der Atherosklerose in verschiedenen Gefässregionen. Med Klin 2002; 97: 221-8.
3. CAPRIE Steering Committee. A randomised, blind trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
4. Birrer M. Makroangiopathie bei Diabetes Mellitus. VASA 2001; 30: 168-74.
5. Belch JF. Metabolic, endocrine and haemodynamic risk factors in the patient with peripheral arterial disease. Diabetes Obes Metab 2002; 4: suppl 2: S7-S13.
6. Cimminiello C. Peripheral arterial disease as a global vascular risk factor. Haematologica 2001; 86: 16-8.
7. Pearson TA. New tools for coronary risk assessment: what are their advantages and limitations? Circulation 2002; 105: 886-92.
8. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993; 88: 1183-97.
9. Papamichael CM, Lekakis JP, Stamatelopoulos KS, Papaioannou TG, Alevizaki MK, Cimponeriu AT et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 2000; 86: 615-8.
10. Papanas N, Tziakas D, Maltezos E, Kekes A, Hatzinikolaou E, Parcharidis G et al. Peripheral arterial occlusive disease as a predictor of the extent of coronary atherosclerosis in patients with coronary artery disease with and without diabetes mellitus. J Int Med Res 2004; 32: 422-8.
11. Danielsen R, Sigvaldason H, Thorgeirson G, Sigfússon N. Predominance of aortic clacification as an atherosclerotic manifestation in women: the Reykjavík Study. J Clin Epidemiol 1996; 49: 383-7.
12. Iribarren C, Sidney S, Sternfield B, Browner WS. Calcification of the aortic arch. JAMA 2000; 283: 2810-5.
13. Witteman JC, Kok FJ, van Saase JL, Valkenburg HA. Aortic calcification as a predictor of cardiovascular mortality. Lancet 1986; ii: 1120-2.
14. Witteman JCM, Kannel WB, Wolf PA, Grobbee DE, Hofman A, D'Agostino RB. Aortic calcification plaques and cardiovascular disease (the Framingham Study). Am J Cardiol 1990; 66: 1060-4.
15. Papanas N, Symeonidis G, Maltezos E, Giannakis I, Mavridis G, Lakasas G, Artopoulos I. Evaluation of aortic arch calcification in type 2 diabetic patients. VASA 2005; 34: 113-7.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.
17. th edition, (Fauci A, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds). New York: McGraw-Hill 1998; pp 9-14.
18. Godwin JD. Conventional CT of the aorta. J Thorac Imaging 1990; 5: 18-31.
19. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108: 1664-72.
20. Wasserman EJ, Shipley NM. Atherothrombosis in acute coronary syndromes: mechanisms, markers, and mediators of vulnerability. Mt Sinai J Med 2006; 73: 431-9.